bpc-157 dosing guidelines protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved How to Take BPC 157
Description
Japan Research has primarily focused on its mechanisms of action, which suggest an enhancement in the processes of angiogenesis (the development of new blood vessels), tissue granulation, and collagen reformation
Some alternative brands in the peptide space lack these details, raising questions about quality control
Suganuma M, Saha A, Fujiki H
[DOI] [PubMed] [Google Scholar] 95
